Monday, 20 Apr 2026
Weather Forecast
  • About Us
  • Contact Us
SUBMIT NEWS
DACH Times™
  • Home
  • Germany
    • Artificial Intelligence
    • Automotive & Mobility
    • Energy
    • Pharmaceuticals
  • Austria
    • Finance
    • Technology
    • Tourism
  • Switzerland
    • FinTech
    • MedTech
    • Pharmaceuticals
  • Europe
  • Press Releases
  • English
    • Français (French)
    • Deutsch (German)
    • Italiano (Italian)
Font ResizerAa
DACH Times™DACH Times™
Search
  • English
    • Français (French)
    • Deutsch (German)
    • Italiano (Italian)
  • Germany
    • Artificial Intelligence
    • Automotive & Mobility
    • Energy
    • Pharmaceuticals
  • Austria
    • Finance
    • Technology
    • Tourism
  • Switzerland
    • FinTech
    • MedTech
    • Pharmaceuticals
  • Europe
  • Press Releases
  • About Us
  • Contact Us
  • Submit News
DACH Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC
DACH Times™ > Blog > Germany > Pharmaceuticals > ‘Minapharm’ inks strategic coop. deal with German pharma giant ‘Bayer’
Pharmaceuticals

‘Minapharm’ inks strategic coop. deal with German pharma giant ‘Bayer’

Last updated: February 28, 2026 9:33 am
Newsroom
Share
SHARE


Minister of Health and Population Khaled Abdel Ghaffar attended the signing ceremony of a strategic cooperation agreement between Minapharm Pharmaceuticals, a leading pharmaceutical company in Egypt and the Middle East and the premier biopharmaceutical company in Africa, and Germany’s pharmaceutical and biotechnology giant “Bayer”.

The deal, signed on the fringe of the 3rd edition of the Global Congress on Population, Health and Human Development (PHDC’25), Egypt is hosting from November 12 to 15, seeks to localize…



Source link

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Previous Article EQL Pharma Gains Approval for Cystohipp in Germany
Next Article German Pharma Co. Says Takeda’s ADHD Drug IP Isn’t Valid

Share DACH Times™!

Your news source on DACH Region
- Advertisement -
Ad image

You Might Also Like

Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany

By Newsroom

Impact of US-UK Pharma Deal on German Drug Prices |

By Newsroom

German Pharma Co. Says Takeda’s ADHD Drug IP Isn’t Valid

By Newsroom

Who stands to lose from new US pharma duties?

By Newsroom
DACH Times™

About US

DACH Times™ is the definitive multilingual news aggregating platform dedicated to the economic, industrial, and cultural heartbeat of Central Europe that includes Germany (D), Austria (A), and Switzerland (CH). In association with EuropeNewswire.net™, we provide press release in the DACH countries. For more information, contact us through these messaging apps: WhatsApp or Telegram

Categories
  • Austria
  • Germany
  • Switzerland
  • Europe
  • Press Releases
Popular News
The Catalyst of Innovation: How Press Release Distribution Fuels Growth in the DACH Region
April 14, 2026
Multilingual PR in the DACH Region: Benefits of Localized Press Releases
April 10, 2026
The Catalyst Effect: How Press Release Distribution Drives Sicily’s 2026 Economic Pillars
April 1, 2026
Refracting the Spectrum of Business Success: The Essential Role of Strategic Press Release Distribution in Italy and Europe
March 24, 2026
Latest News
High Potency APIs Market Size to Reach USD 49.59 Billion by 2031, Driven by Rising Precision Medicine Demand
April 18, 2026
Home Ventilation System Market to Reach USD 41.12 Billion by 2031, Says Mordor Intelligence
April 18, 2026
$42.6 Billion by 2035 — How AI-Powered Content Intelligence Is Driving Engagement
April 17, 2026
$28.4 Billion by 2035 — How Voice Analytics Is Transforming Contact Center Performance
April 17, 2026
  • English
  • Français (French)
  • Deutsch (German)
  • Italiano (Italian)

DACH Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

  • About Us
  • Contact Us
  • Submit News
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?